Silo Pharma partners on intranasal PTSD treatment for FDA review
Silo Pharma, a biopharmaceutical company listed on NASDAQ (SILO), has announced a partnership with Resyca BV, a medical technology provider,…
Étiquette : FDA
FDA Approves Zuranolone for Postpartum Depression Treatment
Postpartum depression (PPD) affects approximately 13% of new mothers, leading to significant emotional distress and difficulties in bonding with their…
French 
English 
German 
Russian 
Spanish 
Belarusian 
Ukrainian